Source:http://linkedlifedata.com/resource/pubmed/id/17828303
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2008-2-28
|
pubmed:abstractText |
SAG (sensitive to apoptosis gene) or ROC2/RBX2 is the second family member of ROC1/RBX1, a component of SCF (Skp1, Cullin, F-box protein) and VCB (von Hippel-Lindau (VHL), Cullin and Elongin B/C) E3 ubiquitin ligases. SAG protected cells from hypoxia-induced apoptosis when overexpressed. We report here that SAG was subjected to hypoxia induction at the levels of mRNA and protein. Hypoxia induction of SAG was largely HIF-1alpha dependent. A consensus HIF-1-binding site, GCGTG was identified in the first intron of the SAG gene. In response to hypoxia, HIF-1 bound to this site and transactivated SAG expression. SAG transactivation required both the intact binding site in cis and HIF-1alpha in trans. On the other hand, like its family member, ROC1, SAG promoted VHL-mediated HIF-1alpha ubiquitination and degradation, which was significantly inhibited upon small interfering RNA silencing of SAG or ROC1. Furthermore, the endogenous HIF-1alpha at both basal and hypoxia-induced levels was significantly increased upon SAG silencing. Finally, SAG forms in vivo complex with Cul-5 and VHL under hypoxia condition. These results suggest an HIF-1-SAG feedback loop in response to hypoxia, as follows: hypoxia induces HIF-1 to transactivate SAG. Induced SAG then promotes HIF-1alpha ubiquitination and degradation. This feedback loop may serve as a cellular defensive mechanism to reduce potential cytotoxic effects of prolonged HIF-1 activation under hypoxia.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxia-Inducible Factor 1, alpha...,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNF7 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin-Protein Ligases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1476-5594
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1404-11
|
pubmed:meshHeading |
pubmed-meshheading:17828303-Animals,
pubmed-meshheading:17828303-Anoxia,
pubmed-meshheading:17828303-Base Sequence,
pubmed-meshheading:17828303-Cell Line,
pubmed-meshheading:17828303-Gene Targeting,
pubmed-meshheading:17828303-HeLa Cells,
pubmed-meshheading:17828303-Humans,
pubmed-meshheading:17828303-Hypoxia-Inducible Factor 1, alpha Subunit,
pubmed-meshheading:17828303-Mice,
pubmed-meshheading:17828303-Mice, Knockout,
pubmed-meshheading:17828303-Molecular Sequence Data,
pubmed-meshheading:17828303-RNA, Messenger,
pubmed-meshheading:17828303-Ubiquitin-Protein Ligases
|
pubmed:year |
2008
|
pubmed:articleTitle |
SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation.
|
pubmed:affiliation |
Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109-096, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|